Related Experiment Video
Updated: Feb 16, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
The association between methionine synthase A2756G polymorphism and hematological cancer: A meta-analysis
Bing Wu1, Kang Liu, Jun-Ping Yang
1Tumor Treatment Center, Renmin Hospital of Wuhan University, Hubei Department of Radiotherapy, The First Affiliated Hospital of Guangxi Medical University, Guangxi State Key Laboratory of Oncology in South China and Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People's Republic of China.
Background:
Numerous studies have focused on the association of methionine synthase (MS) A2756G polymorphism and acute hematological cancer risk. However, the results remain inconsistent. Therefore, a meta-analysis was performed to derive a more precise estimate of the association between them.
Methods:
This meta-analysis involved 25 articles (26 studies) including 8641 hematological cancer patients and 15,498 controls. The pooled odds ratios (ORs) and their corresponding 95% confidence intervals (CIs) of the association between MS A2756G polymorphism and the risk of hematological cancer were calculated.
Results:
Overall, no significant increased risks were found between MS A2756G polymorphism and hematological cancer risk under allelic homozygote (GA vs AA: OR = 0.98, 95% CI = 0.89-1.07, P = .62), heterozygote (GG vs AA: OR = 0.99, 95% CI = 0.85-1.15, P = .91), dominant (AG+GG vs AA: OR = 0.99, 95% CI = 0.90-1.08, P = .93), and recessive (GG vs AG+AA: OR = 1.00, 95% CI = 0.86-1.16, P = .97) models, respectively. In the stratified analyses by ethnicity and source of controls, there were still no significant associations between them in all genetic models.
Conclusions:
Therefore, these findings demonstrate that MS A2756G polymorphism may not be a risk factor for hematological cancer.
Insights
The methionine synthase (MS) A2756G polymorphism is not associated with an increased risk of hematological cancer. This meta-analysis of over 24,000 individuals found no significant link between the MS A2756G variant and cancer development.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The association between methionine synthase (MS) A2756G polymorphism and hematological cancer risk has been investigated in numerous studies.
- Existing research presents inconsistent findings, necessitating a comprehensive meta-analysis to clarify this relationship.
Purpose of the Study:
- To conduct a meta-analysis to precisely estimate the association between the MS A2756G polymorphism and the risk of developing hematological cancer.
- To synthesize evidence from multiple studies to provide a more robust conclusion on the genetic risk factor.
Main Methods:
- A meta-analysis was performed, pooling data from 25 articles comprising 26 distinct studies.
- The analysis included a total of 8,641 hematological cancer patients and 15,498 healthy controls.
- Pooled odds ratios (ORs) and 95% confidence intervals (CIs) were calculated for various genetic models to assess the association.
Main Results:
- No statistically significant increased risks were observed for the MS A2756G polymorphism in relation to hematological cancer across all evaluated genetic models (allelic homozygote, heterozygote, dominant, and recessive).
- Stratified analyses based on ethnicity and the source of control groups also revealed no significant associations.
- Specific ORs and P-values indicated no deviation from the null hypothesis for all comparisons.
Conclusions:
- The findings suggest that the MS A2756G polymorphism is unlikely to be a significant risk factor for hematological cancer.
- Further research may be warranted, but current evidence does not support a causal link between this specific genetic variant and cancer susceptibility.
More Related Videos
Related Concept Videos
ATP Synthase: Structure
ATP Synthase: Mechanism
Cancer Survival Analysis
Directing Effect of Substituents: meta-Directing Groups
Single Nucleotide Polymorphisms-SNPs
Associative Learning
Classical conditioning, also known...

